My watch list
my.bionity.com  
Login  

46 Newest Market Studies

rss

Global Active Pharmaceutical Ingredients Market 2011-2015

.A., Zhejiang Hisun Pharmaceutical Co. Ltd., Ranbaxy Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Watson Pharmaceuticals Inc. and Teva Pharmaceuticals Industries Ltd. Key questions answered in this report...

more

France Pharmaceuticals and Healthcare Report Q4 2012

and conditions, including asthma therapy montelukast in the form of granules in 4mg strength. The letter, for example, includes Merck Sharp & Dohme (MSD)'s proprietary medicine and a generic drug by Teva. BMI...

more

Switzerland Pharmaceuticals and Healthcare Report Q3 2012

medicines arm, has 556 preparations locally approved, while Teva has 345 preparations locally approved. However, the implementation of further price controls on the already low-value medicines sector means...

more

Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Pharmaceuticals, Inc. Teva Pharmaceuticals Pfizer, Inc. SantoSolvo AS BioDelivery Sciences International, Inc. Savient Pharmaceuticals, Inc. Eli Lilly and Company Horizon Pharma Boehringer Ingelheim...

more

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

growth. Currently, the global biosimilar market is at nascent stage. Major pharmaceutical companies including Teva Pharmaceuticals, Sandoz and Hospira have made a strong position for themselves...

more

Global Enzyme Inhibitors Market 2011-2015

Co., Boehringer Ingelheim GmbH, Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Mylan Inc., Johnson and Johnson Ltd., Sanofi S.A., Eli Lilly and Co., Teva Pharmaceutical Industries Ltd., Ranbaxy...

more

Global Pharmaceuticals Market 2011-2015

., Johnson & Johnson Ltd., Mylan Inc., Novo Nordisk A/S, Otsuka Holdings Co. Ltd., Schering-Plough Corp., Shire plc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical, and UCB S.A. Key questions answered...

more

Israel Pharmaceuticals and Healthcare Report Q3 2012

. Key Trends And Developments: ?? Teva’s Q112 results were at first glance strong, as revenues and profits both saw reasonable growth, considering the recent acquisitions of Cephalon and Taiyo. However...

more

Overactive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

. Antares Pharma, Inc. Astellas Pharma Inc. Hisamitsu Pharmaceutical Co., Inc. Teva Pharmaceutical Industries Limited...

more

Croatia Pharmaceuticals and Healthcare Report Q3 2012

belonging to pharmaceutical company PLIVA in Zagreb on March 16 was caused by a static electricity spark, Zagreb Police said. The Croatian firm is part of the Teva group. The explosion happened after...

more

Page 1 From 5
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE